Fanling Meng

3.4k total citations · 2 hit papers
57 papers, 2.8k citations indexed

About

Fanling Meng is a scholar working on Biomedical Engineering, Physiology and Molecular Biology. According to data from OpenAlex, Fanling Meng has authored 57 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Biomedical Engineering, 20 papers in Physiology and 16 papers in Molecular Biology. Recurrent topics in Fanling Meng's work include Nanoplatforms for cancer theranostics (21 papers), Alzheimer's disease research and treatments (19 papers) and Luminescence and Fluorescent Materials (10 papers). Fanling Meng is often cited by papers focused on Nanoplatforms for cancer theranostics (21 papers), Alzheimer's disease research and treatments (19 papers) and Luminescence and Fluorescent Materials (10 papers). Fanling Meng collaborates with scholars based in China, United States and Hong Kong. Fanling Meng's co-authors include Liang Luo, Daniel P. Raleigh, Andisheh Abedini, Xiangliang Yang, C. Bruce Verchere, Xiuxia Wang, Mingming Yin, Liping Huang, Yuting Gao and Yanru Xin and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Fanling Meng

55 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy

2019 509 citations Liping Huang, Yanan Li et al. Nature Communications profile →
Reactive oxygen species-responsive and Raman-traceable hydrogel combining photodynamic and immune therapy for postsurgical cancer treatment

2022 131 citations Yiyi Zhang, Sidan Tian et al. Nature Communications profile →

Peers

Countries citing papers authored by Fanling Meng

Since Specialization

Citations

This map shows the geographic impact of Fanling Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanling Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanling Meng more than expected).

Fields of papers citing papers by Fanling Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanling Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanling Meng. The network helps show where Fanling Meng may publish in the future.

Co-authorship network of co-authors of Fanling Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Fanling Meng. A scholar is included among the top collaborators of Fanling Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanling Meng. Fanling Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recent progress on nanotechnologies for enhancing blood‐brain barrier permeability 2025 ·PubMed ·(unknown), (unknown), Anthony Guiseppi‐Elie, Fanling Meng, Liang Luo	6
2	Tuning the Near-Infrared J-Aggregate of a Multicationic Photosensitizer through Molecular Coassembly for Symbiotic Photothermal Therapy and Chemotherapy 2025 ·ACS Nano ·Zhenyan He, Yuting Gao, Zhen Huang, (unknown), Sidan Tian, Fang Fang, Dan Zhao, Zhong’an Li, Fanling Meng, Ben Zhong Tang, Liang Luo	4
3	A microenvironment-modulating dressing with proliferative degradants for the healing of diabetic wounds 2024 ·Nature Communications ·Lianghui Cheng, (unknown), (unknown), Yuan Lü, Sujuan Liu, (unknown), Liyuan Zhao, Zhenyan He, Fanling Meng, Sidan Tian, Liang Luo	46
4	Conjugation Length‐Dependent Raman Scattering Intensity of Conjugated Polymers 2023 ·Macromolecular Rapid Communications ·Mingming Yin, Liyuan Zhao, Sujuan Liu, Sidan Tian, Fanling Meng, Liang Luo	2
5	Activation of ALOX12 by a multi-organelle-orienting photosensitizer drives ACSL4-independent cell ferroptosis 2022 ·Cell Death and Disease ·Xiuxia Wang, Yuanhong Chen, Yang Xiang, Lianghui Cheng, Zhenyan He, Yanru Xin, (unknown), Fanling Meng, Peijing Zhang, Liang Luo	30
6	Precisely translating computed tomography diagnosis accuracy into therapeutic intervention by a carbon-iodine conjugated polymer 2022 ·Nature Communications ·Mingming Yin, Xiaoming Liu, (unknown), Yuting Gao, Jia‐Cheng Liu, Sidan Tian, Zhiwen Liang, Ye Wang, Fanling Meng, Liang Luo	18
7	Reactive oxygen species-responsive and Raman-traceable hydrogel combining photodynamic and immune therapy for postsurgical cancer treatment breakdown → 2022 ·Nature Communications ·Yiyi Zhang, Sidan Tian, Liping Huang, Yanan Li, Yuan Lü, Hongyu Li, Guiping Chen, Fanling Meng, Gang L. Liu, Xiangliang Yang, Jiasheng Tu, Chunmeng Sun, Liang Luo	131
8	Complete Degradation of a Conjugated Polymer into Green Upcycling Products by Sunlight in Air 2021 ·Journal of the American Chemical Society ·Sidan Tian, Qiang Yue, Chenchen Liu, Mengyang Li, Mingming Yin, Yuting Gao, Fanling Meng, Ben Zhong Tang, Liang Luo	52
9	Time-Programmed Delivery of Sorafenib and Anti-CD47 Antibody via a Double-Layer-Gel Matrix for Postsurgical Treatment of Breast Cancer 2021 ·Nano-Micro Letters ·Liping Huang, Yiyi Zhang, Yanan Li, Fanling Meng, Hongyu Li, Huimin Zhang, Jiasheng Tu, Chunmeng Sun, Liang Luo	50
10	Luminescent AIE Dots for Anticancer Photodynamic Therapy 2021 ·Frontiers in Chemistry ·Zhenyan He, Sidan Tian, Yuting Gao, Fanling Meng, Liang Luo	21
11	Mitochondrion‐Anchored Photosensitizer with Near Infrared‐I Aggregation‐Induced Emission for Near Infrared‐II Two‐Photon Photodynamic Therapy 2021 ·Advanced Healthcare Materials ·Zhenyan He, Yuting Gao, Huimin Zhang, Ying Xue, Fanling Meng, Liang Luo	46
12	Platinum-AIEgen coordination complex for imaging-guided annihilation of cisplatin-resistant cancer cells 2020 ·Chemical Communications ·Zhenyan He, Yuting Gao, Haoke Zhang, Xiuxia Wang, Fanling Meng, Liang Luo, Ben Zhong Tang	14
13	Multicationic AIEgens for unimolecular photodynamic theranostics and two-photon fluorescence bioimaging 2020 ·Materials Chemistry Frontiers ·Yuting Gao, Haoke Zhang, Zhenyan He, Fang Fang, Chao Wang, (unknown), Shangbang Gao, Fanling Meng, Liang Luo, Ben Zhong Tang	23
14	Dual-Color Emissive AIEgen for Specific and Label-Free Double-Stranded DNA Recognition and Single-Nucleotide Polymorphisms Detection 2019 ·Journal of the American Chemical Society ·Yuting Gao, Zhenyan He, Xuewen He, Haoke Zhang, Jun Weng, Xiangliang Yang, Fanling Meng, Liang Luo, Ben Zhong Tang	88
15	A Dual‐Functional Photosensitizer for Ultraefficient Photodynamic Therapy and Synchronous Anticancer Efficacy Monitoring 2019 ·Advanced Functional Materials ·Yuting Gao, Xiuxia Wang, Xuewen He, Zhenyan He, Yang Xiang, Sidan Tian, Fanling Meng, Dan Ding, Liang Luo, Ben Zhong Tang	110
16	Tunable Two-Compartment On-Demand Sustained Drug Release Based on Lipid Gels 2019 ·Journal of Pharmaceutical Sciences ·(unknown), Liping Huang, Yiwei Zhang, Fanling Meng, (unknown), Roy Haskell, Liang Luo	8
17	Recent progress on nanoparticle-based drug delivery systems for cancer therapy 2017 ·Cancer Biology and Medicine ·Yanru Xin, Mingming Yin, Liyuan Zhao, Fanling Meng, Liang Luo	209
18	Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics 2016 ·eLife ·Andisheh Abedini, Annette Plesner, Ping Cao, Zachary Ridgway, Jinghua Zhang, Ling‐Hsien Tu, Chris T. Middleton, (unknown), Daniel J. Sartori, Fanling Meng, Hui Wang, Amy G. Wong, Martin T. Zanni, C. Bruce Verchere, Daniel P. Raleigh, Ann Marie Schmidt	132
19	Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide 2015 ·Journal of Biological Chemistry ·(unknown), (unknown), Kathryn E. Tiller, Fanling Meng, (unknown), Rehana Akter, Daniel P. Raleigh, Peter M. Tessier	37
20	Inhibition of Glycosaminoglycan-Mediated Amyloid Formation by Islet Amyloid Polypeptide and proIAPP Processing Intermediates 2010 ·Journal of Molecular Biology ·Fanling Meng, Daniel P. Raleigh	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact